Comparative Antitumor Activity and Intestinal Toxicity of 5′‐Deoxy‐5‐fluorouridine and Its Prodrug Trimethoxybenzoyl‐5′‐deoxy‐5‐fluorocytidine

Benzer Materyaller

• Cytokines Induce Uridine Phosphorylase in Mouse Colon 26 Carcinoma Cells and Make the Cells More Susceptible to 5′‐Deoxy‐5‐fluorouridine
  Yazar:: Eda, Hiroyuki, ve diğerleri
  Baskı/Yayın Bilgisi: (1993)
• The potential for oral combination chemotherapy of 5′-deoxy-5-fluorouridine, a 5-FU prodrug, and cyclophosphamide for metastatic breast cancer
  Yazar:: Yoshimoto, M, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Pharmacokinetics and bioavailability of oral 5′-deoxy-5-fluorouridine in cancer patients
  Yazar:: Van Der Heyden, S A M, ve diğerleri
  Baskı/Yayın Bilgisi: (1999)
• Comparative Antitumor Activity of 5‐Fluorouracil and 5′‐Deoxy‐5‐fluorouridine in Combination with Radiation Therapy in Mice Bearing Colon 26 Adcnocarcinoma
  Yazar:: Ishikawa, Tohru, ve diğerleri
  Baskı/Yayın Bilgisi: (1989)
• Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase.
  Yazar:: Patterson, A. V., ve diğerleri
  Baskı/Yayın Bilgisi: (1995)